» Authors » Adam C Vandergriff

Adam C Vandergriff

Explore the profile of Adam C Vandergriff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 669
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinh P, Paudel D, Brochu H, Popowski K, Gracieux M, Cores J, et al.
Nat Commun . 2020 Mar; 11(1):1064. PMID: 32111836
Idiopathic pulmonary fibrosis (IPF) is a fatal and incurable form of interstitial lung disease in which persistent injury results in scar tissue formation. As fibrosis thickens, the lung tissue loses...
2.
Su T, Huang K, Daniele M, Hensley M, Young A, Tang J, et al.
ACS Appl Mater Interfaces . 2018 Sep; 10(39):33088-33096. PMID: 30188113
Cardiac stem cell (CSC) therapy has shown preclinical and clinical evidence for ischemic heart repair but is limited by low cellular engraftment and survival after transplantation. Previous versions of the...
3.
Liang H, Huang K, Su T, Li Z, Hu S, Dinh P, et al.
ACS Nano . 2018 Jun; 12(7):6536-6544. PMID: 29943967
Acute liver failure is a critical condition characterized by global hepatocyte death and often time needs a liver transplantation. Such treatment is largely limited by donor organ shortage. Stem cell...
4.
Tang J, Cui X, Caranasos T, Hensley M, Vandergriff A, Hartanto Y, et al.
ACS Nano . 2017 Sep; 11(10):9738-9749. PMID: 28929735
Stem cell transplantation is currently implemented clinically but is limited by low retention and engraftment of transplanted cells and the adverse effects of inflammation and immunoreaction when allogeneic or xenogeneic...
5.
Cores J, Hensley M, Kinlaw K, Rikard S, Dinh P, Paudel D, et al.
Stem Cells Transl Med . 2017 Aug; 6(10):1905-1916. PMID: 28783251
Idiopathic pulmonary fibrosis is a devastating interstitial lung disease characterized by the relentless deposition of extracellular matrix causing lung distortions and dysfunctions. The prognosis after detection is merely 3-5 years...
6.
Dinh P, Cores J, Hensley M, Vandergriff A, Tang J, Allen T, et al.
Respir Res . 2017 Jul; 18(1):132. PMID: 28666430
Background: Resident stem and progenitor cells have been identified in the lung over the last decade, but isolation and culture of these cells remains a challenge. Thus, although these lung...
7.
Tang J, Shen D, Caranasos T, Wang Z, Vandergriff A, Allen T, et al.
Nat Commun . 2017 Jan; 8:13724. PMID: 28045024
Stem cell therapy represents a promising strategy in regenerative medicine. However, cells need to be carefully preserved and processed before usage. In addition, cell transplantation carries immunogenicity and/or tumourigenicity risks....
8.
Vandergriff A, de Andrade J, Tang J, Hensley M, Piedrahita J, Caranasos T, et al.
Stem Cells Int . 2015 Sep; 2015:960926. PMID: 26351465
Despite the efficacy of cardiac stem cells (CSCs) for treatment of cardiomyopathies, there are many limitations to stem cell therapies. CSC-derived exosomes (CSC-XOs) have been shown to be responsible for...
9.
Vandergriff A, Hensley M, Cheng K
J Vis Exp . 2015 May; (98). PMID: 25938862
Cell culture has become increasingly important in cardiac research, but due to the limited proliferation of cardiomyocytes, culturing cardiomyocytes is difficult and time consuming. The most commonly used cells are...
10.
Vandergriff A, Hensley M, Cheng K
Methods Mol Biol . 2015 Apr; 1299:153-60. PMID: 25836582
Cardiomyocytes are frequently used for in vitro models for cardiac research. The isolation of cells is time-consuming and, due to the cells limited proliferative abilities, must be performed frequently. To...